Johnson & Johnson is trading at €241.40, up +4.43%, as healthcare stocks rise 1.37% on strong medical-device earnings from Medtronic and MiniMed Group.
- No fresh company-specific catalyst for September 2, 2026 was identified; recent earnings and litigation developments are earlier background, not a confirmed trigger.
- Broader U.S. markets are also modestly higher, supporting defensive healthcare sentiment.